We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
AstraZeneca's pivotal lung cancer trial fails main goal in late stage trial
Law Law Headlines News
AstraZeneca's combination of two immunotherapy drugs did not meet the main goal in a closely watched late stage study, the company said on Friday.